These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10783183)

  • 21. Evaluating use of continuous treatment teams for persons with mental illness and substance abuse.
    Teague GB; Drake RE; Ackerson TH
    Psychiatr Serv; 1995 Jul; 46(7):689-95. PubMed ID: 7552560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital.
    Greenfield SF; Weiss RD; Tohen M
    Community Ment Health J; 1995 Jun; 31(3):265-77. PubMed ID: 7621663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence.
    Ho AP; Tsuang JW; Liberman RP; Wang R; Wilkins JN; Eckman TA; Shaner AL
    Am J Psychiatry; 1999 Nov; 156(11):1765-70. PubMed ID: 10553741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trial of illness management and recovery in multiple-unit supportive housing.
    Levitt AJ; Mueser KT; Degenova J; Lorenzo J; Bradford-Watt D; Barbosa A; Karlin M; Chernick M
    Psychiatr Serv; 2009 Dec; 60(12):1629-36. PubMed ID: 19952153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of youths with substance use problems and implications for residential treatment.
    Weiner DA; Abraham ME; Lyons J
    Psychiatr Serv; 2001 Jun; 52(6):793-9. PubMed ID: 11376227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of community-based services by rural adolescents with mental health and substance use disorders.
    Anderson RL
    Psychiatr Serv; 2003 Oct; 54(10):1339-41. PubMed ID: 14557517
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of diversion on adults with co-occurring mental illness and substance use: outcomes from a national multi-site study.
    Broner N; Lattimore PK; Cowell AJ; Schlenger WE
    Behav Sci Law; 2004; 22(4):519-41. PubMed ID: 15282838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes.
    Greig RL; Baker A; Lewin TJ; Webster RA; Carr VJ
    Drug Alcohol Rev; 2006 May; 25(3):249-58. PubMed ID: 16753649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of measures used to determine substance abuse in an inpatient psychiatric population.
    Albanese MJ; Bartel RL; Bruno RF; Morgenbesser MW; Schatzberg AF
    Am J Psychiatry; 1994 Jul; 151(7):1077-8. PubMed ID: 8010367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing predictive factors for extended hospitalization at acute psychiatric admission.
    Hopko DR; Lachar D; Bailley SE; Varner RV
    Psychiatr Serv; 2001 Oct; 52(10):1367-73. PubMed ID: 11585954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Veterans Health Administration Transitional work experience vs. job placement in veterans with co-morbid substance use and non-psychotic psychiatric disorders.
    Penk W; Drebing CE; Rosenheck RA; Krebs C; Van Ormer A; Mueller L
    Psychiatr Rehabil J; 2010; 33(4):297-307. PubMed ID: 20374988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.
    Kidorf M; Disney ER; King VL; Neufeld K; Beilenson PL; Brooner RK
    Drug Alcohol Depend; 2004 May; 74(2):115-22. PubMed ID: 15099655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sixteen-year predictors of substance use disorder diagnoses for patients with mental health disorders.
    Irmiter C; Barry KL; Cohen K; Blow FC
    Subst Abus; 2009; 30(1):40-6. PubMed ID: 19197780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic.
    Saxon AJ; Calsyn DA
    Am J Drug Alcohol Abuse; 1995 Aug; 21(3):303-13. PubMed ID: 7484981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adapting a substance abuse court diversion model for felony offenders with co-occurring disorders: initial implementation.
    Broner N; Nguyen H; Swern A; Goldfinger S
    Psychiatr Q; 2003; 74(4):361-85. PubMed ID: 14686460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between diabetes and mortality among persons with co-occurring psychotic and substance use disorders.
    Jackson CT; Covell NH; Drake RE; Essock SM
    Psychiatr Serv; 2007 Feb; 58(2):270-2. PubMed ID: 17287387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief intervention in substance-use among adolescent psychiatric patients: a randomized controlled trial.
    Goti J; Diaz R; Serrano L; Gonzalez L; Calvo R; Gual A; Castro J
    Eur Child Adolesc Psychiatry; 2010 Jun; 19(6):503-11. PubMed ID: 19779855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rehabilitation for adults with severe mental illness and substance use disorders. A clinical trial.
    Lehman AF; Herron JD; Schwartz RP; Myers CP
    J Nerv Ment Dis; 1993 Feb; 181(2):86-90. PubMed ID: 8426176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.